Search for: "Genentech, Inc." Results 141 - 160 of 469
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Jul 2015, 9:11 am by David Jensen
Millan and Bonneville both were promoted from within the organization.Ramona Doyle, Rhodes Project photoDoyle comes from Genentech. [read post]
30 Jun 2015, 3:50 am
 Another two were killed off as reported here (some claims survived in one patent, but these are apparently not of concern to Hospira); this is currently under appeal.The present case Hospira UK Ltd v Genentech Inc [2015] EWHC 1796 (Pat) concerns EP (UK) 1037926, which concerns a combination of trastuzumab with another favourite of pharmaceutical litigation, taxol (and other taxanes). [read post]
28 May 2015, 4:35 pm by David Jensen
Steve Juelsgaard, former executive vice president of Genentech, asked about the company’s “plan B. [read post]
25 May 2015, 5:15 pm by David Jensen
Board member Steven Juelsgaard, former executive vice president of Genentech, raised questions about what might happen if the board rejected the NeoStem application, given that it has only $19 million on hand at last report. [read post]
11 Mar 2015, 9:40 am by Dennis Crouch
Genentech, Inc., 549 U.S. 118 (2007) (challenging licensed patents) Global-Tech Appliances, Inc. v. [read post]
9 Feb 2015, 1:15 am
Now, Darren sinks his paws on the appeal decision in Hospira (UK) Ltd v Genentech, Inc [2015] EWCA Civ 57 (6 February 2015). [read post]
6 Feb 2015, 7:57 am
 Having rejected Figure 2, Birss J should not have found the claims obvious, Genentech alleged.Not so, said Floyd LJ. [read post]
22 Dec 2014, 3:41 am
As Shalini Bengani explains in this post,TufAmerica Inc v W B Music Corp 13-cv-7847(LAK), decided by the US District Court for the Southern District of New York, is another one of those cases. [read post]
15 Dec 2014, 7:25 am
After his earlier post on Hospira v Genentech [on which see also the IPKat earlier note here], Darren provides a catch-up summarizing the large number of comments and the debate that it has generated. [read post]
5 Dec 2014, 10:49 am
Recently, Nyarady’s successful representation of industry leader Edwards Lifesciences against Medtronic, Inc. resulted a 1 billion-dollar settlement. [read post]
21 Oct 2014, 12:00 am
 In Hospira UK Ltd v Genentech Inc[2014] EWHC 1094 (Pat), noted by the IPKat here, Birss J had to deal with inventive step of an ‘incremental’ invention, and he found the inventive concept, which related to a dosage regimen, to be obvious. [read post]
17 Sep 2014, 9:59 pm by Patent Docs
Sundby of Canady & Lortz LLP at the USPTO's Alexandria, VA campus; and from Jeffery Tung, Patent Counsel, Isis Pharmaceuticals; Paul Naik, Vice President, Intellectual Property, Genentech, Inc.; and Dan Sullivan, Director,... [read post]
30 Apr 2014, 3:12 pm by David Jensen
– Directors of the California stem cell agency today selected Randy Mills, the former CEO of Osiris Therapeutics, Inc., of Maryland, to replace Alan Trounson as president of the $3 billion research enterprise. [read post]
24 Apr 2014, 7:40 am by Dennis Crouch
Cir. 2009); In re Genentech Inc., 566 F.3d 1338 (Fed. [read post]
14 Apr 2014, 4:10 am
The IPKat has just been perusing the meaty yet compact decision in the case of Hospira v Genentech (Hospira UK Ltd v Genentech Inc [2014] EWHC 1094 (Pat) (10 April 2014)) which came out last Thursday from Mr Justice Birss. [read post]
12 Apr 2014, 6:39 am by Lawrence B. Ebert
See PharmaStem Therapeutics, Inc. v.ViaCell, Inc., 491 F.3d 1342, 1363-64 (Fed. [read post]